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ABSTRACT
Signaling networks represent the molecular mech-
anisms controlling a cell’s response to various in-
ternal or external stimuli. Most currently available
signaling databases contain only a part of the com-
plex network of intertwining pathways, leaving out
key interactions or processes. Hence, we have de-
veloped SignaLink3 (http://signalink.org/), a value-
added knowledge-base that provides manually cu-
rated data on signaling pathways and integrated data
from several types of databases (interaction, regula-
tion, localisation, disease, etc.) for humans, and three
major animal model organisms. SignaLink3 contains
over 400 000 newly added human protein-protein
interactions resulting in a total of 700 000 interac-
tions for Homo sapiens, making it one of the largest
integrated signaling network resources. Next to H.
sapiens, SignaLink3 is the only current signaling
network resource to provide regulatory information
for the model species Caenorhabditis elegans and
Danio rerio, and the largest resource for Drosophila
melanogaster. Compared to previous versions, we
have integrated gene expression data as well as
subcellular localization of the interactors, therefore
uniquely allowing tissue-, or compartment-specific
pathway interaction analysis to create more accu-
rate models. Data is freely available for download in
widely used formats, including CSV, PSI-MI TAB or
SQL.
INTRODUCTION
Signaling pathways describe the chain of molecular events
of a cell in response to various external or internal signals.
Regulation of many physiological cell functions requires
these signaling pathways to work precisely. Deregulation
of pathways can lead to disturbances in cellular functions
resulting in various diseases. Therefore, it is important to
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analyse and understand these regulatory processes in order
to uncover the workings of these diseases (1).
Traditionally, signaling pathways were considered as a
linear chain of events, rather than a complex network of
intertwining interactions. However, from a functional view-
point, to provide a biologically relevant representation of
the cell’s inner workings we cannot differentiate individ-
ual biological processes as independent pathways, as these
processes have many common interactors and cross-talks
between them (2). Therefore, in the past decade signaling
research started to view biological processes as one single
signaling network, which includes and represents multiple
pathways (3). Although there have been many advances in
this field, most signaling resources still only represent a sub-
set of this complex network.
Currently available signaling databases use interaction
data from high-throughput experiments and text mining,
while others such as SIGNOR (4) and Reactome (5) use
manual curation from literature with differing protocols.
Most of these resources create a detailed representation of
one specific aspect of the regulatory mechanisms of signal-
ing pathways, therefore often leaving out part of the com-
plex network of signaling events. Different levels of detail
also make it difficult to create comparative analyses. There-
fore, we have previously developed SignaLink aiming to
represent signaling networks as connected functional path-
ways. With SignaLink1 (6), we created a network resource
of major signaling pathways by applying uniform man-
ual curation protocols for two model species and humans,
and systematically uncovered pathway cross-talks. In Sig-
naLink2 (7), we introduced the concept of representing sig-
naling pathways and their regulatory interactions in a novel
multi-layered (onion-like) structure. This approach extends
signaling pathways with their regulators, represented in sep-
arate layers. By defining connections between layers, we
are able to represent a more complete network of regula-
tory mechanisms, creating a biologically meaningful model
of signaling networks (8). SignaLink has since provided
researchers a map of global signaling pathways to better
understand and analyze the regulation of signaling path-
ways and pathway cross-talks. Accordingly, SignaLink has
been a widely used tool in signaling research with over
4000 downloads from 400 institutes in 81 countries since
2013.
As advancements in the field emerge, integrating new
data has been a priority in the development of SignaLink.
Hence, we now present SignaLink3, the newest version of
SignaLink. Next to Homo sapiens, we provide signaling
data on three main model organisms––Caenorhabditis el-
egans, Drosophila melanogaster and Danio rerio––in a sin-
gle web resource. Pathway components are represented at
the core of the resource, while their regulatory proteins,
transcription factors, miRNAs, and newly added lncRNAs
make up each layer of the multi-layered structure. In the
update, integrated expression data provides researchers a
way to analyze tissue specificity and subcellular localiza-
tion of signaling networks. SignaLink’s new website was de-
veloped based on feedback from users to provide an easy-
to-use platform with new features and various download
formats.
DESCRIPTION AND CONTENT
With the previous version of SignaLink, we have intro-
duced the novel concept of a multi-layered signaling net-
work. We still adhere to this concept in our update due to
its efficiency of representing biological processes. The aim
of this approach is to represent regulatory mechanisms of
signaling pathways as a whole network, rather than sep-
arate entities as most other resources do. In the multi-
layered structure (Figure 1), the core represents the sig-
naling proteins involved in the 13 pathways included in
SignaLink3 and connections between these pathway pro-
teins compiled together using manual curation. For the pre-
vious versions, this curation was done in-house. For Sig-
naLink3, we not only updated our own curation but also
integrated external curation data from a few selected path-
way resources (such as SIGNOR (4) and Reactome (9))
that applied standardized curation protocols very similar
to the one we have been using (8). The curated pathways in
the core of SignaLink3 contain the original major signaling
pathways: RTK (Receptor Tyrosine Kinase, containing all
MAPK and Insulin subpathways), TGF-, WNT, Hedge-
hog, JAK/STAT, Notch and NHR (Nuclear Hormone Re-
ceptor) pathway as well as five newly added key pathways:
B- and T-cell receptor, Hippo, Toll-like receptor, and innate
immune pathways (Figure 2). Starting with SignaLink1, the
pathway definitions follow the evolution-based concept of
Pires-daSilva and Sommer (10), and now are more com-
plete than in the previous versions. Pathway membership
annotation within SignaLink allows for the identification of
multi-pathway proteins to uncover pathway cross-talks that
are otherwise not clear. As revealed by SignaLink’s previous
version these cross-talks are important in modeling signal-
ing networks in drug-target discovery and uncovering their
pathological role in diseases (11).
After establishing the core, signaling pathways are ex-
tended by using protein-protein and regulatory interaction
resources to create the rest of the onion-like structure. Di-
rect pathway regulators such as scaffold and endocytic pro-
teins obtained from literature curation form the first layer.
Proteins in Layer 1 are key for the spatial regulation of
the signaling flow but often left out from traditional path-
way maps (12). Post-translational modifying enzymes from
PTM-specific resources (e.g. PhosphoSite (13)) make up
the second layer (Figure 1, Layer 2). As compared to the
previous version (7), SignaLink3 only contains experimen-
tally verified interactions. This results in a more reliable and
accurate network resource. Therefore, the number of con-
nections in the post-translational layer decreased, as Sig-
naLink2 also contained predicted interactions (Figure 2C).
Proteins in Layer 2 are mostly responsible for the tempo-
ral regulation of the signaling flow. A major update to Sig-
naLink3 is the large number of directed protein-protein
interactions (PPIs) that were integrated from large-scale
databases such as OmniPath (14), BioGRID (15), ComPPI
(16,17) and IntAct (17) to the third layer (Figure 1, Layer
3). In Layer 3, SignaLink3 now contains more than 350,000
PPIs for pathway proteins (in humans, Figure 2) as com-
pared to the ∼3000 included in the previous version (Figure
2C). All manually curated interactions in SignaLink3 are
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Figure 1. The multilayered structure of SignaLink3. Pathway members and their interactions make up the core of SignaLink. These pathways are extended
by their: direct regulators (proteins that are often not part of the canonical pathway membership), post-translational modifiers (enzymes that could modify
signaling proteins), protein-protein interactions (PPIs), transcriptional and post-transcriptional regulators (transcription factors, miRNAs, and lncRNAs)
This multilayered arrangement represents the complex interactions that regulate the signaling pathways.
2), additionally we also provide the direction of the PPIs
in Layer 3 where possible. This is fundamental, as direc-
tion of interactions are crucial in signal flow (18). Hence,
we have included predictions for both the direction (which
protein has an effect on which) and signage (e.g., stimula-
tory or inhibitory) of the interactions. As a result, of all in-
teractions of SignaLink3 94.3% are directed and 24.2% are
signed. In the case of direction prediction, we used meth-
ods developed by Liu et al. and Rhodes et al. (19,20). We
set up a training set based on the directed interaction data
from the Reactome database, and created a scoring system
calculated from the directions of domain-domain interac-
tions of the proteins. By applying these scores to the PPIs,
we predicted the direction of more than 300,000 undirected
interactions over the four species. With these predictions we
could provide a more accurate and detailed signaling net-
work (Supplementary Figure S1). The sign of an interac-
tion, i.e. the effect each protein has on its target (stimulation
or inhibition) is also an important aspect of interactions
in signaling networks. Therefore, we applied the method of
Vinayagam et al. (21) based on RNAi screens to predict the
signage of the protein-protein interactions where such infor-
mation was not previously supplied in the source databases.
For each interacting pair we calculated the total number
of positive and negative correlations and assigned a score
determining whether the interaction means a positive or a
negative regulation. With this method we predicted the ef-
fect of 116 interactions. Information on the type of interac-
tion (i.e. phosphorylation, co-localization), interaction de-
tection methods and other annotations were also imported
from the integrated resources (e.g. InnateDB (22), TFlink
(https://tflink.net/), TarBase (23)) where available.
The next three layers (Figure 1, Layers 4–6), contain tran-
scriptional and post-transcriptional regulators. The fourth
layer contains transcription factors known to regulate genes
encoding proteins in the inner layers (Core and Layer 1–
3). The number of transcriptional regulatory interactions
increased in SignaLink3 by more than 130,000 connec-
tions (Figure 2C), resulting in altogether 168 817 regu-
latory connections for the four species (using data from
TFlink (https://tflink.net/)). Two major novelties of Sig-
naLink3 is that we doubled the number of miRNAs (Figure
1, Layer 5) integrated from miRDeathDB (24), miRecords
(25), miR2Disease (26), TarBase (23) and starBase (27), and
we included experimentally verified lncRNAs as well from
databases such as lncRInter (28), NPInter (29) and starBase
(27). Regulation by lncRNAs were not included in previ-
ous versions of our resource (Figure 2C). These lncRNAs
in Layer 6 mediate signaling pathways both transcription-
ally and post-transcriptionally. By associating lncRNAs to
pathways and diseases, SignaLink3 provides a comprehen-
sive tool for current signaling research studies.
SignaLink3 integrates signaling data on three major
model organisms next to humans. While compared to hu-
mans, less data is available for model organisms - espe-
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Figure 2. Statistics of SignaLink3 data contents. (A) Number of unique interactors (proteins) involved in each pathway included in SignaLink3 in humans
and three model organisms combined (non-standard abbreviations - IIP: innate immune pathway, TCR: T-cell receptor pathway, BCR: B-cell receptor
pathway, HH: Hedgehog pathway). (B) Number of unique connections (interactions) in each layer in humans and three model organisms combined. (C)
Number of human interactions in each layer of SignaLink3 compared to the previous version. The decrease in the number of interactions in SignaLink3
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for the other species as possible (Figure 2B). SignaLink3
is the largest signaling resource for D. melanogaster with
over 1400 unique proteins and 30 miRNAs. Next to D.
melanogaster SignaLink is the only currently available sig-
naling network resource for C. elegans as well as D. rerio
with the full integration of our previously separate resource,
SignaFish (30). Annotations of pathways are also sparser in
model organisms than in humans, however pathways such
as RTK, WNT/Wingless and Notch can be explored in de-
tail in these species as well (Figure 2A). By providing data in
a unified format on multiple species in a single resource, we
make signaling research more accessible for scientists work-
ing on model species and comparative, evolutionary studies
(31).
Recent advancements in transcriptomics have revealed
that many functionally and pathologically important
molecular mechanisms can differ based on the expression
of a gene in a given tissue or the localization of the pro-
tein within the cell. Therefore, creating tissue-specific sig-
naling networks could pave the way in modeling and drug
discovery for tissue-specific diseases and cancers. Hence, a
major advantage of SignaLink3 is the recently integrated
gene expression data with our signaling and regulatory net-
works. This provides the novel approach of analyzing sig-
naling networks in a tissue-specific manner. We retrieved
tissue-specific gene expression data for all four species in
SignaLink from the Bgee database (31) and combined it
with our network data. As a result, our users can directly
access and filter information about the tissue specificity of
each of the proteins present in SignaLink3. By providing
this data, researchers can reconstruct tissue-specific signal-
ing networks, discover unique regulatory mechanisms, and
model pathologically significant differences in specific tis-
sues. SignaLink3 also contains major and minor cellular lo-
calization information for each interaction using data from
the ComPPI database (17), which we developed earlier. Us-
ing this data, users can filter biologically unlikely PPIs and
create models of compartment-specific biological functions.
CASE STUDY
To demonstrate the new, tissue-specific analysis feature of
SignaLink3, we compared the level of cross-talks between
pathways in different tissue types (Figure 4). By using the
customizable selection options on the download page, we
selected interactions between proteins involved only in the
newly added innate immune pathway (IIP) of H. sapiens.
With the usage of the new tissue filtering function, we only
downloaded interactions present in either the ileum or the
colon. From the exported data file, we calculated the num-
ber of cross-talks between the innate immune pathway and
other pathways included in SignaLink3. We followed the
cross-talk definition from previous versions of SignaLink
(7): if one protein of the interaction was annotated to be in-
volved in the pathway of interest (innate immune pathway in
this case), while its interacting pair was not, we considered
this as a cross-talk between pathways. By carrying out the
same calculations on different tissues, we set up a connec-
tion map of the number of cross-talks of the innate immune
pathway (Figure 3).
As seen from the figure, the number of cross-talks dif-
fers between tissues. We had a significantly larger number
of cross-talks overall in colonic tissues, however it is impor-
tant to note that in the retrieved dataset a much higher per-
centage of interactions were annotated to be expressed in
the colon as in the ileum. However, we also saw slight differ-
ences in the relative number of cross-talks in the two tissues.
For example cross-talks of the innate immune pathway with
the WNT pathway was higher ranked in the colon, while
lower ranked in the ileum (Figure 3). Such analysis can re-
veal unique signaling networks of distinct tissues, and can
be used in understanding disease related alterations. Differ-
ences between the signaling networks in the ileum and colon
could be used in uncovering tissue specific aspects of gut dis-
eases such as differences in the two types of inflammatory
bowel disease: ulcerative colitis and Crohn’s disease.
We can conclude that SignaLink3 is a useful resource for
creating tissue-specific signaling networks as well as discov-
ering pathway cross-talks, providing a tool for comparing
tissues and potentially uncovering the workings of tissue
specific diseases. This demonstrative analysis also shows the
use and importance of new features of SignaLink3. By us-
ing the customizable download page, users can avoid ad-
ditional data cleaning and filtering steps in their pipeline,
which helps in speeding up the analysis.
DATABASE STRUCTURE AND WEBSITE
Alongside newly added features with regards to data con-
tent, SignaLink3 also presents a cleaner, more user-friendly
web interface compared to its previous versions. Since the
last update, based on feedback and suggestions from users
of SignaLink, we aimed to meet our target audience’s needs
in order to provide an easy-to-use tool for both computa-
tional and experimental researchers.
SignaLink3 data is stored in a unified SQLite format.
Each of the interactors are classified by molecule type (pro-
teins, miRNAs, lncRNAs) and annotated by the pathway
they are involved in, as well as their topological features
(e.g. ligand, receptor, transcription factor). Each protein is
further annotated with their major and minor cellular lo-
calization (16), and tissue localization based on integrated
expression data (Figure 4A). Tissues are also represented by
their UBERON identifiers (32) to provide an unambiguous
representation. A unified identifier system is used in the case
of proteins, miRNAs and lncRNAs as well. Proteins are
represented by their unique UniProt (33) (Swiss-Prot) IDs,
although Ensembl (34), HGNC (35) and other alternative
accessions from source databases are also provided. miR-
NAs and lncRNAs are represented by their RNACentral
(36) and miRBase (37) identifiers. In the case of model or-
ganisms, FlyBase (38), WormBase (39) and Zfin (40) cross-
links are available.
Users can access data by navigating to the desired pro-
tein’s page on the website. The protein page displays an in-
teractive network figure of the interactions of the protein of
interest (Figure 4B). Here, the direction and effect are in-
dicated by arrows. Users can customize the view by choos-
ing which layers’ connections they would like to visualize
by clicking the eye symbols in the network control panel.
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Figure 3. Number of cross-talks of the innate immune pathway. (A) Number of cross-talks between IIP and other pathways in SignaLink3 in the ileum.
(B) Number of cross-talks between IIP and other pathways in SignaLink3 in the colon. Width and darkness of lines indicate the number of cross-talks
between the connected pathways. The wider and darker the line is, the more cross-talks there are. The size of the circles indicates the number of unique
proteins involved in the cross-talk with IIP. The size of the IIP node is fixed and does not hold any information (non-standard abbreviations: IIP: innate
immune pathway, TCR: T-cell receptor pathway, BCR: B-cell receptor pathway, HH: Hedgehog pathway).
individually - and tailored to the user’s needs - directly from
the protein page as a new feature (Figure 4C). Interactions
are annotated with the source database the data came from
or PubMed IDs of experimental results next to previously
mentioned direction and signage among others. Currently
the search function is exclusively available to individual pro-
teins, as pathways or tissues cannot be searched for and
browsed. Each protein is annotated by which pathway it be-
longs to or which tissue it is expressed in on the panel shown
in Figure 4A. Pathway and tissue filtering is however avail-
able at download.
The multi-layered structure of SignaLink not only pro-
vides a biologically relevant representation of signaling net-
works but also caters for customizable download options.
On the new download page, users can select any subset
of SignaLink, choosing specific species, pathways or lay-
ers. With the integrated tissue and subcellular localization
data, users can select specific tissues and create a tissue spe-
cific network. We also aim to provide a more straightfor-
ward way of obtaining data with step-by-step options for
customizing the downloaded dataset. SignaLink3 can be
downloaded in many widely used formats such as CSV, PSI-
MITAB (41) or BioPAX (42). The entire dataset of Sig-
naLink3 can also be downloaded as a complete SQL file.
DISCUSSION AND FUTURE PLANS
SignaLink3 provides an extended and updated resource of
signaling networks for humans and three model species. Sig-
naLink3 builds on the previously developed multi-layered
network structure and complements it with novel fea-
tures and annotations to allow creating cell-compartment
or tissue-specific networks. SignaLink3 extends signaling
pathways by integrating regulatory connections scattered
across different databases in one single resource. The de-
rived multi-layered structure presents a more detailed net-
work of signaling events. Since 2013, the community of Sig-
naLink users has grown, reaching researchers in 81 coun-
tries with 25,000 visits. Based on the citations on the pub-
lication of the previous version of SignaLink (7), the re-
source proved to be a useful tool in cancer research (43),
drug discovery (44), and signaling pathway research (45).
These works emphasize that SignaLink provides useful and
easy-to-use features filling the current gaps in signaling net-
work research. Other large-scale data sources such as Om-
niPath (14) and SIGNOR (Licata et al. 2020) integrating
SignaLink data also indicate the need for such a compre-
hensive resource. By cross-linking data with such resources,
SignaLink’s data can reach a wider platform of users. With
the rapidly growing amount of data available, one of our
priorities is providing an up-to-date resource for our com-
munity. Feedback from users - pointing out missing features
or personal preferences - has also been considered in the
development of SignaLink3. Accordingly, we provide new,
previously missing features for an easier and more complete
reconstruction of context-dependent signaling networks.
SignaLink3 is a useful tool for biological modeling, aid-
ing drug discovery research. For these purposes it is cru-
cial to have a thorough annotation of interactions. In Sig-
naLink3, we include predictions for both the direction
and effect of interactions, as well as providing informa-
tion on the type of the interaction (e.g., phosphorylation,
co-localization, physical association). This additional in-
formation allows simulating biochemical reactions and aid
in analysis of signal transduction pathways. Another novel
feature of SignaLink3 is the possibility of creating tissue
specific networks. As pointed out in a review (18) on multi-
layered signaling network resources - including SignaLink2
- none of the reviewed databases provided tissue specific
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Figure 4. Updated protein page design of SignaLink3. (A) Basic information on a protein with multiple identifiers and cross-links. Annotated by the path-
way, topological features, molecule type and subcellular localization as well as tissue expression. (B) Interactive network representation of the connections
of the protein. Users can choose which type of interactions they would like to visualize. (C) Further information on the connections of the protein. As a
novel feature, connections can be individually downloaded by category or all connections of the protein can be obtained by clicking the ‘Download all
interactions’ button.
then, a ‘Tissue distribution’ tool has been developed as a
part of the Reactome analysis toolset, which makes it possi-
ble to create tissue specific signaling networks (5). However,
this feature is only available for human signaling proteins
while in SignaLink3 we additionally provide tissue annota-
tions for three model species as well. With the integration
of gene expression data in the novel version, we were able
to further fill the gap of analyzing tissue-specific signaling
networks, allowing users to select specific tissues of interest.
With the integrated tissue and cellular localization infor-
mation, and a large number of newly added interactions,
SignaLink3 extends signaling pathways with transcrip-
tional, post-transcriptional, post-translational and now
lncRNA regulators in four species, making it one of the
largest integrated signaling network resources currently
available (Figure 2). With a new, easy-to-use interactive
website and customizable download options developed
based on user feedback, SignaLink3 is a leading tool
in biological modeling, cancer research and understand-
ing diseases such as inflammatory bowel disease (IBD),
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In further developments, we aim to include emerging
analysis methods and computational approaches in future
versions of SignaLink. Our automated pipeline makes it
simple to integrate novel data to always provide an up-to-
date source of signaling network data with bi-annual data
updates. With our growing community, we plan to priori-
tize user feedback to make SignaLink fit the needs of re-
searchers. As the prevalence of epigenetics research rises,
we also plan to integrate epigenetics information, such as
methylation profiles or chromatin regulation data to future
updates of SignaLink. Currently, transcription factor - tar-
get gene interactions mostly consider transcription factor
binding sites in the promoter regions of the target genes.
In future updates we plan to further extend these binding
sites to more distant enhancer regions as well. With the in-
troduction of the option of creating tissue-specific networks
we made a leading step in signaling network research. How-
ever, with the emergence of single-cell sequencing technolo-
gies we plan to provide a way to create cell-type specific net-
works with further developments.
DATA AVAILABILITY
SignaLink data is freely available for download in widely
used formats, including CSV, PSI-MI TAB or SQL at http:
//SignaLink.org.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank the comments and feedback of the users of Sig-
naLink as well as the suggestions and ideas from the past
and current members of the LINKgroup, VellaiLab, and
KorcsmarosLab (previously NetBiol group). We are also
grateful for the useful advices of those who attended train-
ing courses about SignaLink.
FUNDING
L.G., M.O. and M.M. are supported by the BBSRC Nor-
wich Research Park Biosciences Doctoral Training Partner-
ship [BB/M011216/1, BB/S50743X/1]; the work of T.K.
and D.M. was supported by the Earlham Institute (Nor-
wich, UK) in partnership with the Quadram Institute (Nor-
wich, UK) and strategically supported by a UK Research
and Innovation (UKRI) Biotechnological and Biosciences
Research Council (BBSRC) Core Strategic Programme
Grant for Genomes to Food Security [BB/CSP1720/1] and
its constituent work packages [BBS/E/T/000PR9819,
BBS/E/T/000PR9817], as well as a BBSRC ISP
grant for Gut Microbes and Health [BB/R012490/1]
and its constituent projects [BBS/E/F/000PR10353,
BBS/E/F/000PR10355]; P.S. was supported by funding
from the European Research Council (ERC) under the
European Union’s Horizon 2020 research and innovation
programme [694679]; P.C., E.A. and T.V. were supported
by the Hungarian National Research, Development and
Innovation Office [K131458, PD131839, K132439]; V.A.B.
and T.V. were also supported by the ELKH/MTA-ELTE
Genetics Research Group [01062]; P.C. was also sup-
ported by the Higher Education Institutional Excellence
Programme of the Ministry of Human Capacities in
Hungary within the framework of the molecular biology
thematic programmes of Semmelweis University and the
Thematic Excellence Programme [Tématerületi Kiválósági
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